Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Future (FUTR) by Gordon Best in The Motley Fool
- Avoid Light Science Technologies Holdings (LST) by Steve Moore in ShareProphets
- Avoid DG Innovate (DGI) by Steve Moore in ShareProphets
- Avoid Eckoh (ECK) by Steve Moore in ShareProphets
- Buy Rightmove (RMV) by UBS
- Buy Taylor Wimpey (TW.) by Jon Smith in The Motley Fool
- Strong Buy Bluebird Merchant Ventures (DI) (BMV) by Hot Stock Rockets in ShareProphets
- Buy Trainline (TRN) by UBS
- Avoid Vodafone Group (VOD) by Charlie Keough in The Motley Fool
- Buy Henry Boot (BOOT) by Deutsche Bank
- Buy Cairn Homes (CDI) (CRN) by Deutsche Bank
- Buy Accsys Technologies (AXS) by Deutsche Bank
- Hold 3i Group (III) by Deutsche Bank
- Hold Taylor Wimpey (TW.) by Deutsche Bank
- Hold Volution Group (FAN) by Deutsche Bank
- Hold Persimmon (PSN) by Deutsche Bank
- Hold Redrow (RDW) by Deutsche Bank
- Hold Relx plc (REL) by Deutsche Bank
- Hold S4 Capital (SFOR) by Deutsche Bank
- Hold Glenveagh Properties (CDI) (GLV) by Deutsche Bank
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 15 open tips for Physiomics (PYC)
| Latest Bid : 1.10p | Latest Ask : 1.40p |
| High Today : 1.31p | Low Today : 1.10p |
| This Years High : 3.00p | This Years Low : 0.95p |
| Volume : 392,472 | MKT Cap : £1.69M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2022-10-12 11:35:00 12/10/2022 | 50.00% |
| Avoid | Steve Moore | Premium Only | 2022-10-04 13:45:00 04/10/2022 | 40.48% |
| Avoid | Steve Moore | Premium Only | 2022-07-07 15:50:00 07/07/2022 | 56.90% |
| Sell | Gary Newman | Premium Only | 2021-12-27 11:55:00 27/12/2021 | 81.34% |
| Avoid | Steve Moore | Premium Only | 2021-05-10 11:40:00 10/05/2021 | 78.99% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1.10p | Latest Ask : 1.40p |
| High Today : 1.31p | Low Today : 1.10p |
| This Years High : 3.00p | This Years Low : 0.95p |
| Volume : 392,472 | MKT Cap : £1.69M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2022-10-12 11:35:00 12/10/2022 | 50.00% |
| Avoid | Steve Moore | Premium Only | 2022-10-04 13:45:00 04/10/2022 | 40.48% |
| Avoid | Steve Moore | Premium Only | 2022-07-07 15:50:00 07/07/2022 | 56.90% |
| Sell | Gary Newman | Premium Only | 2021-12-27 11:55:00 27/12/2021 | 81.34% |
| Avoid | Steve Moore | Premium Only | 2021-05-10 11:40:00 10/05/2021 | 78.99% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000